DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Tsai A, Wu SP, Haseltine E. et al.
Physiologically based pharmacokinetic modeling of CFTR modulation in people with cystic fibrosis transitioning from mono or dual regimens to triple-combination elexacaftor/tezacaftor/ivacaftor.
Pulm Ther 2020;
6 (02) 275-286
We do not assume any responsibility for the contents of the web pages of other providers.